Table 4.
Rasche et al. | Xie et al. | Chen et al. | |
---|---|---|---|
Treatment groups | Tonsillectomy versus control | Tonsillectomy versus control | Tonsillectomy versus control |
Daily proteinuria |
(>1.5 g) 9/16 versus 25/39 |
0.91 ± 1.12 versus 1.09 ± 1.43 |
0.973 ± 0.924 versus 1.17 ± 1.02 (>1.0 g) 19/54 versus 23/58 |
sCr | 2.4 ± 2.8 versus 1.6 ± 0.9 | 1.07 ± 0.27 versus 1.07 ± 0.31 | 1.08 ± 0.33 versus 1.07 ± 0.275 |
CCr (≥70 ml/min) | Not available |
Renal survival rate: 98 versus 89% at 10 years (ns) 90 versus 63.8% at 20 years (efficacy at 20 years; p < 0.05) |
CR rate: 46.3 versus 27.5% (p = 0.04) Relapse rate: 38.9 versus 48.3% (p = 0.317) Not improved rate: 16.7 versus 34.5% (p = 0.031) ESRD at less than 15 years: 3.7 versus 12.1% (p = 0.059) |
CCr (<70 ml/min) | Renal survival rate: 40% and 60% at 10 years (ns) | Not available | Not available |
sCr serum creatinine, CCr creatinine clearance, CR clinical remission, ESRD end-stage renal disease, ns not significant